Nosiheptide
CAS No. 56377-79-8
Nosiheptide( Multhiomycin | RP 9671 )
Catalog No. M24551 CAS No. 56377-79-8
Nosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 126 | In Stock |
|
| 10MG | 216 | In Stock |
|
| 25MG | 378 | In Stock |
|
| 50MG | 561 | In Stock |
|
| 100MG | 798 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNosiheptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionNosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus.
-
DescriptionNosiheptide is a thiopeptide antibiotic produced by Streptomyces actuosus. Nosiheptide has been widely used as a feed additive for animal growth. Nosiheptide inhibits bacterial protein synthesis and bears a unique indole side ring system and regiospecific hydroxyl groups on the characteristic macrocyclic core.
-
In VitroNosiheptide exhibits extremely potent activity against all contemporary Staphylococcus aureus strains tested including multiple drug-resistant clinical isolates, with MIC values ≤ 0.25 mg/L. Nosiheptide is also highly active against Enterococcus spp and the contemporary hypervirulent BI strain of Clostridium difficile but is inactive against most Gram-negative strains tested. Time-kill analysis reveals Nosiheptide to be rapidly bactericidal against Staphylococcus aureus in a concentration- and time-dependent manner, with a nearly 2-log kill noted at 6 hours at 10X MIC. Furthermore, Nosiheptide is found to be non-cytotoxic against mammalian cells at >> 100X MIC, and its anti-Staphylococcus aureus activity is not inhibited by 20% human serum. Notably, Nosiheptide exhibits a significantly prolonged post-antibiotic effect against both healthcare- and community-associated Staphylococcus aureus compared to vancomycin.
-
In VivoNosiheptide (20 mg/kg; intraperitoneal injection; injected at 1 and 8 h post-infection; female CD1 mice) provids significant protection against mortality. Ten out of 10 of the Nosiheptide-treated mice remains alive on day 3, while 6/10 of the controls died on day 1. Animal Model:Eight week old female CD1 mice injected with HA-Staphylococcus aureus strain Sanger 252 Dosage:20 mg/kg Administration:Intraperitoneal injection; injected at 1 and 8 h post-infection Result:Provided significant protection against mortality.
-
SynonymsMulthiomycin | RP 9671
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
RecptorAntibiotic|Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56377-79-8
-
Formula Weight1222.36
-
Molecular FormulaC51H43N13O12S6
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (102.26 mM; Need ultrasonic)
-
SMILESOC1=C(C2=NC(C(NC(C(N)=O)=C)=O)=CS2)N=C(C3=CSC(C4NC(C5=CSC(C(CC(C(OCC6=C7C(C)=C(NC7=CC=C6)C(SC4)=O)=O)O)NC(C8=CSC(/C(NC(C(C(O)C)NC(C9=CSC%10=N9)=O)=O)=C\C)=N8)=O)=N5)=O)=N3)C%10=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haste NM, et al. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2012 Dec;65(12):593-8.
molnova catalog
related products
-
CRK12-IN-1
CRK12-IN-1 is a potent CRK12 inhibitor with insecticidal activity and exhibits inhibitory effects on Trypanosoma brucei (T.b. brucei) and Trypanosoma congolense (T. congolense) with EC50s of 1.3 and 18 nM, respectively, rapidly killing the pathogenic cells.
-
Tebipenem
Tebipenem is an orally available carbapenem antibiotic. It displays broad-spectrum activity against Gram-positive and -negative bacteria.
-
Adenosine 5-monophos...
Adenosine 5'-monophosphate disodium salt (Adenosine Phosphate Disodium) is a purine nucleotide involved in ATP metabolism and is used to study the effects of ATP on cells and organisms.
Cart
sales@molnova.com